Registered investigators may submit a Request for Service Application (RSA) for Clinical Trials Funding Assistance through the NHLBI Gene Therapy Resource Program (GTRP).  NHLBI’s Gene Therapy Group reviews such RSAs and determines the amount of funding that can be provided through the program, if any, and any contingencies relevant to the particular study and RSA. The CCC acts as the contractual agent for this component of the program and manages the disbursement of funds.  Further, the CCC provides support to the GTRP in the oversight of study/investigator compliance with regulatory requirements and any study-specific contingencies related to funds disbursement.